packageErenumab

erenumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Erenumab is a monoclonal antibody that blocks the calcitonin gene-related peptide receptor and is used to prevent migraine. It is authorised in the European Union for migraine and is an approved medicine.

Summary written by glm-5.3-flash from Wikidata Q28209017 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:erenumab
ATC codes:N02CD01
DrugBank:DB14039
Wikidata:Q28209017

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown